HEI Stock Analysis: Heico | NYSE
Aerospace & Defense | NYSE, USA | Market Cap: 50.569m USD | 12M Return: 11.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 165M
EPS Trend: 99.4%
Qual. Beats: 6
Rev. Trend: 97.5%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
HEICO Corporation is a U.S.-based industrial company operating in the aerospace, defense, and electronics sectors through two business segments. The Flight Support Group supplies jet engine and aircraft replacement parts, thermal insulation products, and a wide range of hydraulic, pneumatic, structural, and electromechanical components, while also providing repair and overhaul services for aircraft parts, avionics, instruments, and military aircraft systems. The Electronic Technologies Group produces electro-optical infrared simulation and test equipment, RF and microwave products, power electronics, specialty semiconductors, antennas, communications receivers, and radiation detection equipment, among other components.
The company serves commercial, regional, general aviation, and military customers across the United States and internationally, and is classified within the Industrials sector under the Aerospace & Defense sub-industry. HEICOs dual-segment structure - combining parts distribution and MRO services with higher-technology electronic components - is a common model in the aerospace aftermarket, where suppliers support both original equipment manufacturers and existing fleets. The company was incorporated in 1957, is headquartered in Hollywood, Florida, and has been listed on the NYSE since 1992.
- Commercial aviation aftermarket recovery drives Flight Support revenue growth
- Defense electronics demand lifts Electronic Technologies Group margins
- Serial acquisitions expand niche aerospace and defense product portfolio
| Net Income: 789.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 0.24 > 1.0 |
| NWC/Revenue: 35.28% < 20% (prev 39.15%; Δ -3.87% < -1%) |
| CFO/TA 0.10 > 3% & CFO 997.1m > Net Income 789.6m |
| Net Debt (2.40b) to EBITDA (1.37b): 1.76 < 3 |
| Current Ratio: 2.92 > 1.5 & < 3 |
| Outstanding Shares: last quarter (141.0m) vs 12m ago 0.32% < -2% |
| Gross Margin: 40.06% > 18% (prev 42.12%; Δ -2.06% > 0.5%) |
| Asset Turnover: 55.54% > 50% (prev 51.09%; Δ 4.46% > 0%) |
| Interest Coverage Ratio: 9.04 > 6 (EBIT TTM 1.16b / Interest Expense TTM 128.2m) |
| A: 0.18 (Total Current Assets 2.64b - Total Current Liabilities 903.6m) / Total Assets 9.59b |
| B: 0.42 (Retained Earnings 4.03b / Total Assets 9.59b) |
| C: 0.13 (EBIT TTM 1.16b / Avg Total Assets 8.84b) |
| D: 1.14 (Book Value of Equity 4.77b / Total Liabilities 4.20b) |
| Altman-Z'' = 4.63 = AA |
| DSRI: 1.02 (Receivables 866.5m/716.1m, Revenue 4.91b/4.13b) |
| GMI: 1.05 (GM 42.12% / 40.06%) |
| AQI: 1.01 (AQ_t 0.68 / AQ_t-1 0.67) |
| SGI: 1.19 (Revenue 4.91b / 4.13b) |
| TATA: -0.02 (NI 789.6m - CFO 997.1m) / TA 9.59b) |
| Beneish M = -2.83 (Cap -4..+1) = A |
As of July 10, 2026, the stock is trading at USD 352.13 with a total of 298,131 shares traded. Over the past week, the price has changed by -2.10%, over one month by +7.92%, over three months by +20.13% and over the past year by +11.22%.
Current recommended Stop Loss: 331.10 (which is 6% or 2 ATR below the current price).
Heico has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy HEI.
- StrongBuy: 9
- Buy: 4
- Hold: 7
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 386.1 | 9.6% |
P/E Trailing = 64.5437
P/E Forward = 51.8135
P/S = 10.2965
P/B = 10.527
P/EG = 2.7826
Revenue TTM = 4.91b USD
EBIT TTM = 1.16b USD
EBITDA TTM = 1.37b USD
Long Term Debt = 2.58b USD (from longTermDebt, last quarter)
Short Term Debt = 3.40m USD (from shortTermDebt, last quarter)
Debt = 2.61b USD (from shortLongTermDebtTotal, last quarter) + Leases 25.7m
Net Debt = 2.40b USD (calculated: Debt 2.61b - CCE 210.3m)
Enterprise Value = 53.0b USD (50.6b + Debt 2.61b - CCE 210.3m)
Interest Coverage Ratio = 9.04 (Ebit TTM 1.16b / Interest Expense TTM 128.2m)
EV/FCF = 57.21x (Enterprise Value 53.0b / FCF TTM 926.0m)
FCF Yield = 1.75% (FCF TTM 926.0m / Enterprise Value 53.0b)
FCF Margin = 18.85% (FCF TTM 926.0m / Revenue TTM 4.91b)
Net Margin = 16.08% (Net Income TTM 789.6m / Revenue TTM 4.91b)
Gross Margin = 40.06% ((Revenue TTM 4.91b - Cost of Revenue TTM 2.94b) / Revenue TTM)
Gross Margin QoQ = 41.40% (prev 38.60%)
Tobins Q-Ratio = 5.52 (Enterprise Value 53.0b / Total Assets 9.59b)
Interest Expense / Debt = 4.91% (Interest Expense 128.2m / Debt 2.61b)
Taxrate = 17.72% (182.8m / 1.03b)
NOPAT = 954.0m (EBIT 1.16b * (1 - 17.72%))
Current Ratio = 2.92 (Total Current Assets 2.64b / Total Current Liabilities 903.6m)
Debt / Equity = 0.55 (Debt 2.61b / totalStockholderEquity, last quarter 4.77b)
Debt / EBITDA = 1.76 (Net Debt 2.40b / EBITDA 1.37b)
Debt / FCF = 2.59 (Net Debt 2.40b / FCF TTM 926.0m)
Total Stockholder Equity = 4.43b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.93% (Net Income 789.6m / Total Assets 9.59b)
RoE = 17.82% (Net Income TTM 789.6m / Total Stockholder Equity 4.43b)
RoCE = 16.53% (EBIT 1.16b / Capital Employed (Equity 4.43b + L.T.Debt 2.58b))
RoIC = 11.25% (NOPAT 954.0m / Invested Capital 8.48b)
WACC = 9.07% (E(50.6b)/V(53.2b) * Re(9.33%) + D(2.61b)/V(53.2b) * Rd(4.91%) * (1-Tc(0.18)))
Discount Rate = 9.33% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 86.67 | Cagr: 0.37%
[DCF] Terminal Value 75.67% ; FCFF base≈860.4m ; Y1≈986.3m ; Y5≈1.45b
[DCF] Fair Price = 307.9 (EV 19.4b - Net Debt 2.40b = Equity 17.0b / Shares 55.2m; r=9.07% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 99.42 | EPS CAGR: 29.05% | SUE: 4.0 | # QB: 6
Revenue Correlation: 97.49 | Revenue CAGR: 22.32% | SUE: 4.0 | # QB: 1
EPS current Quarter (2026-07-31): EPS=1.48 | Chg30d=+0.39% | Revisions=+56% | Analysts=18
EPS current Year (2026-10-31): EPS=6.05 | Chg30d=-0.37% | Revisions=+72% | GrowthEPS=+23.4% | GrowthRev=+17.2%
EPS next Year (2027-10-31): EPS=6.89 | Chg30d=+0.89% | Revisions=+84% | GrowthEPS=+13.9% | GrowthRev=+9.7%
[Analyst] Revisions Ratio: +81% (up=41, down=3)